EUCTR2005-001258-26-DK进行中（未招募）不适用
An 8-week extension to a randomized, double blind, parallel group, active-controlled, multi-center, 14 week study to evaluate the effectiveness of a valsartan versus an amlodipine treatment stratgey in achieving blood presure control in patients with stage 1 or stage 2 hypertension or uncontrolled on present monotherapy
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 入组人数
- 224
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •1. MSSBP = 140 mm Hg, and/or MSDBP = 90 mm Hg and currently treated with either
- •valsartan 320 mg/ HCTZ 25 mg or amlodipine 10 mg/ HCTZ 25 mg at Visit C
- •2. Written informed consent to participate in the extension study
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range
排除标准
- •1. Premature discontinuation in the core study or failure to comply with the core study protocol
- •2. Any patient that the investigator decides should not participate in the extension study
研究者
相似试验
进行中（未招募）
1 期
An 8-week extension to a randomized, double blind, parallel group, active-controlled, multi-center, 14 week study to evaluate the effectiveness of a valsartan versus an amlodipine treatment stratgey in achieving blood presure control in patients with stage 1 or stage 2 hypertension or uncontrolled on present monotherapyEUCTR2005-001258-26-GBovartis Pharma Services AG
进行中（未招募）
不适用
An 8-week extension to a randomized, double blind, parallel group, active-controlled, multi-center, 14 week study to evaluate the effectiveness of a valsartan versus an amlodipine treatment stratgey in achieving blood pressure control in patients with stage 1 or stage 2 hypertension or uncontrolled on present monotherapyEUCTR2005-001258-26-DEovartis Pharma Services AG224
进行中（未招募）
1 期
An 8-week extension to a randomized, double blind, parallel group, active-controlled, multi-center, 14 week study to evaluate the effectiveness of a valsartan versus an amlodipine treatment strategy in achieving blood presure control in patients with stage 1 or stage 2 hypertension or uncontrolled on present monotherapyEssential hypertensionEUCTR2005-001258-26-IEovartis Pharma Services AG
进行中（未招募）
不适用
An 8-week extension to a randomized, double blind, parallel group, active-controlled, multi-center, 14 week study to evaluate the effectiveness of a valsartan versus an amlodipine treatment strategy in achieving blood presure control in patients with stage 1 or stage 2 hypertension or uncontrolled on present monotherapyEUCTR2005-001258-26-FIovartis Pharma Services AG224
进行中（未招募）
不适用
An 8 week extension to a randomized, double-blind, parallel group, active-controlled, multi-center, 14 week study to evaluate the effectiveness of a valsartan versus anamlodipine treatment strategy in achieving blood pressure control in patients with stage 1 or stage 2 hypertension or uncontrolled on present monotherapy - NDEssential hypertensionMedDRA version: 6.1Level: PTClassification code 10015488EUCTR2005-001258-26-ITOVARTIS FARMA1,244